My Life, Our Future: Genotyping for Progress in Hemophilia | NHLBI Trans-Omics for Precision Medicine Skip to main content

My Life, Our Future: Genotyping for Progress in Hemophilia

Short Name
MLOF
Institution(s)
Blood Works Northwest
Type of Omics
WGS
RNASeq
Approx. Sample Size 2188 (ph2), 2959 (ph3)
Disease/Phenotype
Hemophilia
Starting Phase
Phase 2
dbGaP ID
phs001515
TOPMed Accession #
Please see this TOPMed Project's Parent Studies.
Omics Center(s) Phase 2
New York Genome Center Genomics
Omics Center(s) Phase 3
Baylor College of Medicine Human Genome Sequencing Center
Omics Center(s) Phase 6
Baylor College of Medicine Human Genome Sequencing Center
Northwest Genomics Center
Phases Involved
2
3
6
Populations
Males and Females of All Ages with Hemophilia A
PI

Barbara Konkle
Co-PI
Jill Johnsen
Contact

Ann Whitney
NIH Program Officer
Pankaj Qasba
Phenotype Liaison
Sarah Ruuska
Steering Committee Representatives
Barbara Konkle
Jill Johnsen
P&P primary
Barbara Konkle
P&P alternate
Jill Johnsen
Project
MLOF
Released
No